MT-ND5 and cancer: A recent study suggests yes and showed that murine cellular models of cancer-derived ND5 mtDNA heteroplasmic mutations regulate cancer metabolism and tumor biology, with redox imbalance contributing to a Warburg-like metabolic shift to glycolysis.